Heidi’s Law
Sponsored By: Representative Smith (NJ)
Introduced
Summary
Adds methadone to federal and DOT workplace drug-testing panels and creates an annual review process so Health and Human Services and Transportation can add other drugs to testing lists. The bill would set firm timelines for HHS and DOT to update testing rules after each change.
Show full summary
- Workers and patients on methadone treatment would be newly covered by federal workplace drug tests and by Department of Transportation testing panels. This makes methadone a listed substance that testers must detect.
- DOT-regulated transportation employees would face methadone testing under updated DOT rules. DOT must issue regulations within 60 days after HHS publishes its final notice expanding testing.
- HHS would have 90 days to revise the Mandatory Guidelines to add methadone and must review the guidelines every year to identify other substances to add. After each HHS final notice DOT must update transportation testing procedures within 60 days to match the revised guidelines.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 0 benefits, 0 costs, 2 mixed.
DOT testing rules to include methadone
If enacted, the DOT Secretary would issue regulations within 60 days after HHS publishes a final notice to add methadone to transportation employee drug-testing panels. DOT regulations would need to be consistent with HHS's revised Mandatory Guidelines. DOT would update testing rules each time HHS adds new substances by final notice. This change would apply to employers and employees covered by Department of Transportation testing programs.
Federal workplace tests add methadone
If enacted, the HHS Secretary would revise federal workplace drug testing rules within 90 days to add methadone to the opiate test panel. HHS would review the Mandatory Guidelines every year and could add other drugs when needed. HHS would publish a final notice in the Federal Register after any revision. This change would affect federal workplace drug testing laboratories, federal employers covered by the Guidelines, and employees subject to those testing programs.
Sponsors & CoSponsors
Sponsor
Smith (NJ)
NJ • R
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govTake It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in